Before a planned trip to the U.S., Cheng wanted to get vaccinated against COVID-19. To do so, he asked a friend working at a cold-chain logistics company in southeast China to pretend he was employed by the firm, allowing Cheng access to one of the country’s experimental shots.
Cheng, a business owner from Beijing, now plans to fly to Guangdong province and pay as much as $91 to take two doses of what he believes is a vaccine being produced by a unit of Sinopharm, the state-backed Chinese developer at the front of the global COVID-19 vaccine race.
"You just transfer him the money via Alipay, but he won’t tell you the details because apparently it’s black market,” said Cheng, referring to a digital payments platform that’s used widely in China. Cheng asked to only be identified by his last name as he fears reprisal for speaking publicly.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.